Parkinson's disease

A new study shows that adjusting deep brain stimulation settings based on wearable sensor data and brain recordings can enhance walking in Parkinson’s disease. The personalized approach improved gait performance and revealed neural signatures linked to mobility gains.

A groundbreaking study suggests that Parkinson’s disease may begin in the kidneys, where a toxic protein builds up and travels to the brain. This discovery could reshape our understanding of the disease’s origins and risk factors.

A new study finds that people who consume more ultra-processed foods are significantly more likely to exhibit early warning signs of Parkinson’s disease, raising concerns about diet’s role in neurological health long before diagnosis.

Once considered little more than reversible brain lesions, deep brain stimulators can now fine-tune their output using brain activity as a guide. This adaptive method may revolutionize how doctors treat neurological and psychiatric disorders.

Psilocybin therapy produced surprising benefits in a small study of people with Parkinson’s disease. Beyond improving mood, the psychedelic treatment was linked to better motor function and cognitive performance.

Dancing can significantly reduce depression in Parkinson's disease, a new study suggests. Not only did participants report feeling better, but brain scans also showed decreased activity in a key area linked to emotional regulation.

A study found that levodopa-induced dyskinesia disconnects the motor cortex from movement control, allowing abnormal movements. Ketamine reduced these movements, restored some brain control, and altered neural interactions, showing promise as a potential treatment.

Consuming unsweetened caffeinated coffee is linked to a lower risk of Alzheimer’s, Parkinson’s, and related mortality, while sweetened or artificially sweetened coffee showed no such benefits.

Parkinson’s patients were observed to consume less hydrogenated oils and more non-hydrogenated oils, olive oil, and mayonnaise.

Recent research identified hundreds of genetic variants influencing brain structure sizes, linking larger volumes to Parkinson’s risk and smaller volumes to ADHD.

Researchers found that reducing the activity of a protein called Drp1 helps protect brain cells in Parkinson’s disease by restoring mitochondrial function and cleaning up toxic proteins, offering potential new treatments for the condition.

A new study finds that adaptive deep brain stimulation, which adjusts in real time to brain activity, reduces Parkinson’s symptoms by 50%, offering more personalized treatment and fewer side effects compared to traditional stimulation methods.

Researchers found that blocking a protein called Activin A can prevent dyskinesia, a debilitating side effect of Parkinson's treatment, potentially allowing patients to stay on levodopa longer without developing uncontrollable movements.

Researchers developed a model using blood proteins and clinical data to predict Parkinson's disease risk up to 15 years before symptoms appear. This early detection could help prevent or delay the progression of the disease.

Researchers at the University of Florida developed an AI-powered video-processing system that analyzes hand movement tests to detect subtle changes in Parkinson’s disease symptoms, enabling more precise and accessible monitoring of disease progression from home.